This article analyzes the Judgment of the Court of Justice of the European Union of 19 June
2025, delivered in Case C-200\/24, which declares that a total ban on the promotion of pharmacies imposed by a Member State is contrary to EU law. In the case at hand, Poland failed to demonstrate that the national measure genuinely pursued the protection of public health, either by rational consumption of medicines or by safeguarding the professional independence of pharmacists. The paper also examines European case law distinguishing between the advertising of medicinal products and the advertising of pharmacies, in order to clarify the legitimate scope of restrictions on commercial communications. Finally, it offers a brief reflection on the potential impact of this judgment on
Spanish pharmaceutical regulation.<\/p>\n","protected":false},"excerpt":{"rendered":"
This article analyzes the Judgment of the Court of Justice of the European Union of 19 June2025, delivered in Case C-200\/24, which declares that a total ban on the promotion of pharmacies imposed by a Member State is contrary to EU law. In the case at hand, Poland failed to demonstrate that the national measure… <\/p>\n